29 Jan 2020 --- US-based personalized nutrition company Baze has received approval from the US Food and Drug Administration (FDA) for its at-home blood collection process, which allows customers to assess their blood nutrient status. The company then analyzes the blood samples to offer nutrition plans and supplement subscriptions specific to individual needs and deficiencies. Although the nutrient testing kit may appear to be another luxury technology item in the personalized nutrition space, Alex Boches, Baze COO and US General Manager, tells NutritionInsight that the company aims to catapult its innovation as an accessible product for more at-risk populations, addressing major nutritional health concerns.
.JPG)
